Physician profile
Jose E Rodriguez
NPI 1316980998
$5,598.77
in general payments reported to CMS, 2019-2025
32 companies · $553 in 2025
The $553 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,233 · 2020: $1,369 · 2021: $398 · 2022: $409 · 2023: $206 · 2024: $431 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $3,305.36 | 2019-2024 | |
| Centinel Spine, LLC | $253.93 | 2022 | |
| Xtant Medical INC | $193.24 | 2025 | |
| Amgen INC. | $179.61 | 2019-2024 | Krystexxa |
| Surgalign Spine Technologies, INC. | $163.84 | 2019-2021 | |
| Encore Medical, Lp | $159.07 | 2021 | |
| Hydrocision, INC. | $149.56 | 2025 | Tenjet |
| Providence Medical Technology, INC. | $126.14 | 2019-2022 | |
| Horizon Therapeutics Plc | $116.11 | 2023 | Krystexxa |
| Si-Bone, INC. | $100.86 | 2019-2020 | |
| Intrinsic Therapeutics | $86.08 | 2022 | |
| Abbott Laboratories | $81.82 | 2023-2024 | Xience Sierra, Xience Skypoint, Nc Trek Neo |
| Lilly USA, LLC | $79.01 | 2024-2025 | Mounjaro, Zepbound |
| Zimmer Biomet Holdings, INC. | $77.14 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $54.99 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $49.28 | 2022-2024 | Gelsyn-3 |
| Siemens Medical Solutions USA, INC. | $46.37 | 2024 | Cios Alpha, Cios Spin |
| Medline Industries Lp | $45.35 | 2024 | |
| Dexcom, INC. | $43.73 | 2024-2025 | Dexcom G6 Transmitter |
| Spinal Elements, INC. | $40.13 | 2024 | |
| Thrombolex, INC. | $29.57 | 2025 | Bashir Endovascular Catheter |
| Electronic Waveform Lab, INC. | $28.57 | 2021 | |
| Boston Scientific Corporation | $24.31 | 2025 | Varithena Administration Pack |
| Fidia Pharma USA INC. | $24.06 | 2024 | Hymovis |
| Omnilife Science, INC | $21.68 | 2025 | |
| Ibsa Pharma INC. | $19.49 | 2025 | Licart, Tirosint, Flector |
| Pacira Pharmaceuticals Incorporated | $18.79 | 2019 | |
| Ermi LLC | $18.07 | 2021-2022 | |
| Vericel Corporation | $17.59 | 2019 | |
| Mimedx Group, INC. | $17.32 | 2024 | |
| Medtronic, INC. | $15.39 | 2022 | |
| Endo Pharmaceuticals INC. | $12.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.